⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Susan G. Komen ® to Deliver Urgent Message at Second Annual October Party in Pink Event: “Ending Deaths from Breast Cancer is Within Our Grasp; Together We Will Make it Happen”
businesswire.com
ACN
BX
GILD
AIG
As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
accessnewswire.com
NNVC
GILD
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
businesswire.com
GILD
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
businesswire.com
MRK
GILD
Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure
businesswire.com
GILD
Duffy & Shanley Wins PRNEWS & Chief Marketer’s Best PR Event Award for Bonds U.S. Launch
businesswire.com
BJ
GILD
Neo Launches with $100M to Secure AI Software Across the Enterprise
globenewswire.com
S
PANW
SHOP
NVDA
MSFT
GOOG
AMZN
CRM
ADBE
IBM
INTC
AMD
QCOM
META
TWLO
LI
CVNA
DDOG
CRWD
OKTA
PLTR
SNOW
SMCI
MU
AMAT
LRCX
ASML
ORCL
SAP
CSCO
FTNT
CHKP
VRTX
REGN
GILD
BIIB
AZN
PFE
MRNA
BMY
AMGN
LLY
ABBV
NVO
SNPS
CDNS
MCHP
NXPI
ON
ADI
TXN
CRSP
EXAS
ALGN
TDOC
ROKU
COIN
PYPL
HOOD
Cell and Gene Therapy Global Market Opportunities And Strategies To 2035 Published — Analyzes Hospitals, Cancer Care Centers and Other End Users
globenewswire.com
GILD
NVS
BMY
JNJ
SRPT
VRTX
AMGN
Duchenne Muscular Dystrophy Treatment Market Report (2025-2034) Published, Segments Intravenous, Subcutaneous, and Oral Routes Across Three Pharmacy Channels
globenewswire.com
SRPT
PFE
BIIB
REGN
GILD
JNJ
ABBV
NVS
SNY
CAPR
SLDB
WVE
EDIT
Slone Partners Places Amer Mirza, PhD, as Chief Scientific Officer at Prolynx
prnewswire.com
GILD
XOMA